Pharmacology, Toxicology and Pharmaceutical Science
Absence
7%
Adverse Event
14%
Antibiotics
5%
Antimalarial Agent
33%
Artemether Plus Benflumetol
25%
Artemisinin
36%
Artemisinin Derivative
5%
Artesunate
14%
Azithromycin
5%
Chloroquine
35%
Cholera
9%
Cholera Vaccine
5%
Clinical Trial
13%
Combination Therapy
13%
Dihydroartemisinin
21%
Diseases
7%
Drug
41%
Drug Resistance
8%
El Tor
5%
Elimination
17%
Ensure
6%
Fever
7%
Glucose 6 Phosphate Dehydrogenase
63%
Glucose 6 Phosphate Dehydrogenase Deficiency
12%
Hemoglobin
16%
Hemolysis
10%
IC50
7%
Incidence
22%
Infection
26%
Malaria
100%
Malaria Falciparum
40%
Mefloquine
9%
Mixed Infection
6%
Parasite
15%
Parasite Clearance
8%
Parasitemia
21%
Piperaquine
17%
Plasmodium falciparum
19%
Plasmodium vivax
13%
Plasmodium Vivax Malaria
47%
Prevalence
14%
Primaquine
72%
Pyrimethamine Plus Sulfadoxine
6%
Quinine
7%
Randomized Controlled Trial
6%
Recurrent Disease
21%
Salmonella
7%
Salmonella Enterica Serovar Typhi
9%
Typhoid Fever
15%
Vaccine
6%
Medicine and Dentistry
Analysis
14%
Antimalarial Agent
19%
Arm
12%
Artemether/Lumefantrine
9%
Artemisinin
23%
Artesunate
8%
Assessment
9%
Blood Culture
14%
Chemotherapeutic Agent
10%
Child
15%
Chloroquine
32%
Cholera
9%
Clearance
7%
Clinical Trial
8%
Combination Therapy
13%
Development
11%
Diagnosis
18%
Diseases
16%
Drug
9%
Fever
9%
Follow up
14%
Genotype
17%
Glucose 6 Phosphate Dehydrogenase
23%
Health
7%
Health Care Cost
17%
Hemoglobin
10%
Household
12%
Incidence
24%
Infection
20%
Inpatient
8%
Malaria
62%
Malaria Falciparum
22%
Meta-Analysis
13%
Parasite (Microbiology)
12%
Parasite Clearance
14%
Parasitemia
19%
Patient
48%
Plasmodium
8%
Plasmodium Vivax Malaria
23%
Polymerase Chain Reaction
9%
Primaquine
30%
Rapid Diagnostic Test
14%
Recrudescence
10%
Salmonella
14%
Salmonella Enterica Serovar Typhi
9%
Serotype
8%
Surveillance
9%
Therapeutic Procedure
69%
Typhoid Fever
41%
Vaccine
9%
Nursing and Health Professions
Analysis
7%
Artemether Plus Benflumetol
5%
Blood Culture
9%
Chloroquine
5%
Control
8%
Culture
8%
Diagnosis
20%
Diseases
11%
Drug
6%
Electric Potential
5%
Ensure
5%
Fever
6%
Gestational Age
5%
Glucose 6 Phosphate Dehydrogenase
20%
Glucose 6 Phosphate Dehydrogenase Deficiency
8%
Household
5%
Infection
6%
Laboratory
5%
Malaria
67%
Measurement
8%
Meta Analysis
7%
Patient
31%
Plasmodium Vivax Malaria
12%
Practice Guideline
7%
Primaquine
16%
Procedures
24%
Resident
5%
Sample
9%
Systematic Review
7%
Time
5%
Typhoid Fever
19%
Woman
7%